Your browser doesn't support javascript.
loading
Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker.
Akdogan, Özlem; Atak Yücel, Aysegül; Gök Sargin, Zeynep; Sönmez, Cemile; Esendagli Yilmaz, Güldal; Özenirler, Seren.
Afiliação
  • Akdogan Ö; Department of Gastroenterology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Atak Yücel A; Department of Immunology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Gök Sargin Z; Department of Gastroenterology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Sönmez C; Sexually Transmitted Research Laboratory, National Public Health Institution of Turkey, Ankara, Turkey.
  • Esendagli Yilmaz G; Department of Medical Pathology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Özenirler S; Department of Gastroenterology, Faculty of Medicine, Gazi University, Ankara, Turkey.
J Clin Exp Hepatol ; 9(1): 29-33, 2019.
Article em En | MEDLINE | ID: mdl-30765936

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article